Lifileucel for liposarcoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 3 Aug 2026: Trial registered, NCT07741877
  2. 2 Oct 2026: Trial started, NCT07741877

The trials

NCT07741877: A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma

State
Under way
Phase
Phase 2
People
80 planned
Started
2 Oct 2026
Primary completion
1 Sep 2033
Arms
Lifileucel
Results
None posted
  1. 3 Aug 2026: Trial registered
  2. 2 Oct 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Also known as Amtagvi.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.